ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT for Off label use: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 17 adverse event reports in the FDA FAERS database where ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT was used for Off label use.
Most Reported Side Effects for ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Haemarthrosis | 3,360 | 31.7% | 12 | 398 |
| Haemorrhage | 2,925 | 27.6% | 19 | 399 |
| Fall | 709 | 6.7% | 13 | 228 |
| Arthralgia | 561 | 5.3% | 3 | 102 |
| Muscle haemorrhage | 554 | 5.2% | 1 | 127 |
| Limb injury | 525 | 5.0% | 1 | 82 |
| Drug ineffective | 513 | 4.9% | 8 | 47 |
| Joint injury | 511 | 4.8% | 3 | 82 |
| Contusion | 496 | 4.7% | 5 | 100 |
| Pain | 484 | 4.6% | 4 | 88 |
| Joint swelling | 354 | 3.3% | 2 | 84 |
| Epistaxis | 350 | 3.3% | 3 | 58 |
| Factor viii inhibition | 286 | 2.7% | 5 | 102 |
| Anti factor viii antibody positive | 280 | 2.7% | 6 | 52 |
| Head injury | 275 | 2.6% | 3 | 74 |
Other Indications for ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT
Factor viii deficiency (4,268)
Product used for unknown indication (2,568)
Prophylaxis (1,107)
Haemophilia (796)
Haemorrhage (751)
Haemorrhage prophylaxis (343)
Haemostasis (86)
Haemarthrosis (67)
Immune tolerance induction (53)
Acquired haemophilia (50)
Other Drugs Used for Off label use
LENALIDOMIDE (5,767)
ECULIZUMAB (3,550)
CERTOLIZUMAB PEGOL (2,256)
ABOBOTULINUMTOXINA (2,170)
LEVETIRACETAM (2,161)
APREMILAST (1,995)
PROPRANOLOL (1,576)
CETIRIZINE (1,416)
HUMAN IMMUNOGLOBULIN G (1,129)
THALIDOMIDE (1,033)